Changchun BCHT Biotechnology Co. (SHA:688276)
China
· Delayed Price · Currency is CNY 18.05
-0.08 (-0.44%)
Apr 30, 2026, 9:44 AM CST
SHA:688276 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | -267.12 | -262.58 | 232.09 | 501.01 | 181.54 | 243.55 | Upgrade
|
| Depreciation & Amortization | 130.96 | 130.96 | 104.18 | 91.99 | 70.94 | 68.34 | Upgrade
|
| Other Amortization | 19.13 | 19.13 | 9.15 | 7.01 | 5.68 | 0.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.06 | -0.06 | 2.55 | 0.9 | 0.73 | 2.19 | Upgrade
|
| Asset Writedown & Restructuring Costs | 72.09 | 72.09 | 0.78 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 34.41 | 34.41 | 0.44 | -0.69 | -0.31 | 1.02 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 6.13 | 31.67 | 12.54 | 5.35 | Upgrade
|
| Other Operating Activities | 104.64 | 12.61 | 40.06 | 55.96 | 41.34 | 82.59 | Upgrade
|
| Change in Accounts Receivable | 466.31 | 466.31 | 121.92 | -691.36 | -171.36 | -40.04 | Upgrade
|
| Change in Inventory | -64.51 | -64.51 | 20.66 | -33.53 | 7.89 | -166.47 | Upgrade
|
| Change in Accounts Payable | -111.41 | -111.41 | -127.49 | 327.65 | -109.1 | -51.67 | Upgrade
|
| Operating Cash Flow | 318.7 | 231.21 | 406.5 | 255.21 | 39.82 | 140.3 | Upgrade
|
| Operating Cash Flow Growth | -7.79% | -43.12% | 59.28% | 540.93% | -71.62% | -32.92% | Upgrade
|
| Capital Expenditures | -408.78 | -406.49 | -542.43 | -470.66 | -290.73 | -632.88 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.08 | 0.06 | - | 0.04 | - | 0.02 | Upgrade
|
| Investment in Securities | - | -50 | - | -168 | - | -62.64 | Upgrade
|
| Other Investing Activities | - | - | 0.94 | - | 2.02 | - | Upgrade
|
| Investing Cash Flow | -408.7 | -456.42 | -541.48 | -638.63 | -288.72 | -695.51 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 67.5 | Upgrade
|
| Long-Term Debt Issued | - | 334.65 | 336.84 | 196.91 | - | - | Upgrade
|
| Total Debt Issued | 388.42 | 334.65 | 336.84 | 196.91 | - | 67.5 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -67.5 | Upgrade
|
| Long-Term Debt Repaid | - | -172.24 | -254.48 | -176.44 | - | - | Upgrade
|
| Total Debt Repaid | -225.19 | -172.24 | -254.48 | -176.44 | - | -67.5 | Upgrade
|
| Net Debt Issued (Repaid) | 163.23 | 162.41 | 82.36 | 20.47 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 19 | - | - | 1,413 | Upgrade
|
| Common Dividends Paid | -76.05 | -75.03 | -62.05 | -62.61 | -41.28 | - | Upgrade
|
| Other Financing Activities | - | - | -2.35 | - | - | -10.4 | Upgrade
|
| Financing Cash Flow | 87.19 | 87.38 | 36.97 | -42.14 | -41.28 | 1,402 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.19 | -0.16 | 0.7 | 0.5 | 1.66 | -0.1 | Upgrade
|
| Net Cash Flow | -3 | -138 | -97.31 | -425.06 | -288.52 | 847.05 | Upgrade
|
| Free Cash Flow | -90.08 | -175.28 | -135.92 | -215.46 | -250.91 | -492.58 | Upgrade
|
| Free Cash Flow Margin | -15.27% | -28.97% | -11.06% | -11.81% | -23.42% | -40.98% | Upgrade
|
| Free Cash Flow Per Share | -0.26 | -0.43 | -0.33 | -0.52 | -0.61 | -1.25 | Upgrade
|
| Cash Interest Paid | - | - | 2.35 | - | - | 0.33 | Upgrade
|
| Cash Income Tax Paid | 18.77 | 21.99 | 139.52 | 121.49 | 77.93 | 102.54 | Upgrade
|
| Levered Free Cash Flow | -70.91 | 35.3 | -213.55 | -334.43 | -297.86 | -467.9 | Upgrade
|
| Unlevered Free Cash Flow | -70.91 | 35.3 | -212.6 | -333.99 | -297.86 | -467.69 | Upgrade
|
| Change in Working Capital | 224.64 | 224.64 | 11.12 | -432.65 | -293.73 | -269.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.